潜在不适当用药与医疗资源利用及费用增加相关
该回顾性队列研究利用2011-2015年美国医疗支出面板调查数据,纳入社区居住的65岁及以上老年人,采用2019版AGS Beers标准定义潜在不适当用药(PIM)。结果显示PIM处方5年期间患病率为34.4%,PIM暴露与住院、急诊就诊和门诊就诊增加及医疗费用升高相关。
要点
- PIM处方5年期间患病率为34.4%。
- PIM暴露与住院(aIRR=1.17)、急诊就诊(aIRR=1.26)和门诊就诊(aIRR=1.18)增加相关。
- PIM暴露与门诊、处方药和总医疗费用升高相关。
核心结论
- 在美国老年人中PIM处方率仍较高,PIM暴露与医疗资源利用增加和费用升高相关。
研究设计与样本
- 回顾性队列研究,使用2011-2015年美国医疗支出面板调查(MEPS)数据,纳入社区居住的65岁及以上成年人。
主要发现
- PIM处方5年期间患病率为34.4%。
- PIM暴露与住院风险增加相关(aIRR=1.17;95%CI=1.08-1.26;P<.001)。
- PIM暴露与急诊就诊增加相关(aIRR=1.26;95%CI=1.17-1.35;P<.001)。
- PIM暴露与门诊就诊增加相关(aIRR=1.18;95%CI=1.14-1.21;P<.001)。
- PIM暴露与门诊费用(边际成本$116;95%CI=$105-$243;P<.001)、处方药费用($128;95%CI=$72-$199;P<.001)和总医疗费用($458;95%CI=$295-$664;P<.001)升高相关。
关键数值与推荐
- PIM定义基于2019年美国老年医学会Beers标准(AGS Beers Criteria®)的可操作化定义。
- 采用负二项模型分析医疗资源利用关联,广义线性模型(对数链接和伽马分布)分析费用关联。
- 采用倾向评分逆概率治疗加权进行敏感性分析,结果相似。
临床怎么用
- 在老年患者中应关注PIM处方,考虑实施基于证据的减处方干预以可能减少不必要的医疗资源利用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: To examine the prevalence of potentially inappropriate medication (PIM) prescribing and its association with healthcare utilization and related expenditures utilizing nationally representative data from the United States. DESIGN: Retrospective cohort study. SETTING: The 2011-2015 Medical Expenditure Panel Survey (MEPS). PARTICIPANTS: Community-dwelling sample of U.S. adults aged 65 and older during the first round of each MEPS cycle. MEASUREMENTS: A qualified definition operationalized from the 2019 American Geriatrics Society Beers Criteria® was used to estimate the prevalence of PIM prescribing over the study period. Negative binomial models were assembled to examine associations between PIM exposure and healthcare utilization including hospitalizations, emergency department (ED) visits, and outpatient provider visits. Generalized linear models with the log link function and gamma distribution were used to analyze associations between PIM exposure and healthcare expenditures. Sensitivity analyses were conducted utilizing inverse probability treatment weighting using propensity scores for being prescribed a PIM. RESULTS: The period prevalence of PIM prescribing over the 5-year sample was 34.4%. PIM prescribing was positively associated with hospitalizations (adjusted incidence rate ratio [aIRR] = 1.17; 95 confidence interval [CI] = 1.08-1.26; P < .001), ED visits (aIRR = 1.26; 95% CI = 1.17-1.35; P < .001), and outpatient provider visits (aIRR = 1.18; 95% CI = 1.14-1.21; P < .001). PIM exposure was associated with higher marginal costs within outpatient visits ($116; 95% CI = $105-$243; P < .001), prescription medications ($128; 95% CI = $72-$199; P < .001), and total healthcare expenditures ($458; 95% CI = $295-$664; P < .001). Similar results were found in our propensity score analyses. CONCLUSION: PIMs continue to be prescribed at a high rate among older adults in the United States. Our results suggest that receipt of PIMs is associated with higher rates of healthcare utilization and increased costs across the healthcare continuum. Further work is needed to implement evidence-based deprescribing interventions that may in turn reduce unnecessary healthcare utilization.
引用
- Clark CM, Shaver AL, Aurelio LA, et al. Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs. J Am Geriatr Soc. 2020. PMID: 32757494. doi:10.1111/jgs.16743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。